LUCAR-20SP
/ Legend Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 15, 2024
A Study of LUCAR-20SP in Subjects With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
(clinicaltrials.gov)
- P1 | N=42 | Recruiting | Sponsor: Peking University Cancer Hospital & Institute
New P1 trial • Hematological Malignancies • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology
1 to 1
Of
1
Go to page
1